1
Verkouteren, Babette J. A., Wakkee, Marlies, Reyners, An K. L., Nelemans, Patty, Aarts, Maureen J. B., Racz, Emoke, Terra, Jorrit B., Devriese, Lot A., Alers, Robert-Jan, Kapiteijn, Ellen, van Doorn, Remco, Bekkenk, Marcel W., Reinders, Marie G. H. C., Mosterd, Klara
Veröffentlicht in: Verkouteren , B J A , Wakkee , M , Reyners , A K L , Nelemans , P , Aarts , M J B , Racz , E , Terra , J B , Devriese , L A , Alers , R-J , Kapiteijn , E , van Doorn , R , Bekkenk , M W , Reinders , M G H C & Mosterd , K 2021 , ' Eight years of experience with vismodegib for advanced and multiple basal cell carcinoma patients in the Netherlands : a retrospective cohort study ' , British Journal of Cancer . https://doi.org/10.1038/s41416-020-01220-w;
2021
Veröffentlicht in: Verkouteren , B J A , Wakkee , M , Reyners , A K L , Nelemans , P , Aarts , M J B , Racz , E , Terra , J B , Devriese , L A , Alers , R-J , Kapiteijn , E , van Doorn , R , Bekkenk , M W , Reinders , M G H C & Mosterd , K 2021 , ' Eight years of experience with vismodegib for advanced and multiple basal cell carcinoma patients in the Netherlands : a retrospective cohort study ' , British Journal of Cancer . https://doi.org/10.1038/s41416-020-01220-w;
2021
2
Verkouteren, B.J.A., Wakkee, M., Reyners, A.K.L., Nelemans, P., Aarts, M.J.B., Racz, E., Terra, J.B., Devriese, L.A., Alers, R.J., Kapiteijn, E., van Doorn, R., Bekkenk, M.W., Reinders, M.G.H.C., Mosterd, K.
Veröffentlicht in: Verkouteren , B J A , Wakkee , M , Reyners , A K L , Nelemans , P , Aarts , M J B , Racz , E , Terra , J B , Devriese , L A , Alers , R J , Kapiteijn , E , van Doorn , R , Bekkenk , M W , Reinders , M G H C & Mosterd , K 2021 , ' Eight years of experience with vismodegib for advanced and multiple basal cell carcinoma patients in the Netherlands: a retrospective cohort study ' , British Journal of Cancer , vol. 124 , no. 7 , pp. 1199-1206 . https://doi.org/10.1038/s41416-020-01220-w;
2021
Veröffentlicht in: Verkouteren , B J A , Wakkee , M , Reyners , A K L , Nelemans , P , Aarts , M J B , Racz , E , Terra , J B , Devriese , L A , Alers , R J , Kapiteijn , E , van Doorn , R , Bekkenk , M W , Reinders , M G H C & Mosterd , K 2021 , ' Eight years of experience with vismodegib for advanced and multiple basal cell carcinoma patients in the Netherlands: a retrospective cohort study ' , British Journal of Cancer , vol. 124 , no. 7 , pp. 1199-1206 . https://doi.org/10.1038/s41416-020-01220-w;
2021
3
4
Brink, M., Kahle, X.U., Vermaat, J.S.P., Zijlstra, J.M., Chamuleau, M., Kersten, M.J., Durmaz, M., Plattel, W.J., Lugtenburg, P.J., Stevens, W., Mous, R., de Vries, E.G.E., van der Poel, M.W.M., Panday, P.V.N., Huls, G., van Meerten, T., Nijland, M.
Veröffentlicht in: Brink , M , Kahle , X U , Vermaat , J S P , Zijlstra , J M , Chamuleau , M , Kersten , M J , Durmaz , M , Plattel , W J , Lugtenburg , P J , Stevens , W , Mous , R , de Vries , E G E , van der Poel , M W M , Panday , P V N , Huls , G , van Meerten , T & Nijland , M 2021 , ' Impact of rituximab biosimilars on overall survival in diffuse large B-cell lymphoma: a Dutch population-based study ' , Blood advances , vol. 5 , no. 15 , pp. 2958-2964 . https://doi.org/10.1182/bloodadvances.2021004295;
2021
Veröffentlicht in: Brink , M , Kahle , X U , Vermaat , J S P , Zijlstra , J M , Chamuleau , M , Kersten , M J , Durmaz , M , Plattel , W J , Lugtenburg , P J , Stevens , W , Mous , R , de Vries , E G E , van der Poel , M W M , Panday , P V N , Huls , G , van Meerten , T & Nijland , M 2021 , ' Impact of rituximab biosimilars on overall survival in diffuse large B-cell lymphoma: a Dutch population-based study ' , Blood advances , vol. 5 , no. 15 , pp. 2958-2964 . https://doi.org/10.1182/bloodadvances.2021004295;
2021
5
Brink, Mirian, Kahle, Xaver U., Vermaat, Joost S. P., Zijlstra, Josee M., Chamuleau, Martine, Kersten, Marie Jose, Durmaz, Mujde, Plattel, Wouter J., Lugtenburg, Pieternella J., Stevens, Wendy, Mous, Rogier, de Vries, Elisabeth G. E., van der Poel, Marjolein W. M., Panday, Prashant V. Nannan, Huls, Gerwin, van Meerten, Tom, Nijland, Marcel
Veröffentlicht in: Brink , M , Kahle , X U , Vermaat , J S P , Zijlstra , J M , Chamuleau , M , Kersten , M J , Durmaz , M , Plattel , W J , Lugtenburg , P J , Stevens , W , Mous , R , de Vries , E G E , van der Poel , M W M , Panday , P V N , Huls , G , van Meerten , T & Nijland , M 2021 , ' Impact of rituximab biosimilars on overall survival in diffuse large B-cell lymphoma : a Dutch population-based study ' , Blood , vol. 5 , no. 15 , pp. 2958-2964 . https://doi.org/10.1182/bloodadvances.2021004295;
2021
Veröffentlicht in: Brink , M , Kahle , X U , Vermaat , J S P , Zijlstra , J M , Chamuleau , M , Kersten , M J , Durmaz , M , Plattel , W J , Lugtenburg , P J , Stevens , W , Mous , R , de Vries , E G E , van der Poel , M W M , Panday , P V N , Huls , G , van Meerten , T & Nijland , M 2021 , ' Impact of rituximab biosimilars on overall survival in diffuse large B-cell lymphoma : a Dutch population-based study ' , Blood , vol. 5 , no. 15 , pp. 2958-2964 . https://doi.org/10.1182/bloodadvances.2021004295;
2021
6
7
8
9
10